Evidence map›Paper›PMID 31286885›Full record

ArticleBMC developmental biology2019

Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression.

Michael Reimer, Kirthi Pulakanti, Linzheng Shi, Alex Abel, Mingyu Liang, Subramaniam Malarkannan, Sridhar Rao

Open access · hybridAbstract read
In one paragraph

Article in BMC developmental biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Michael ReimerBlood Research Institute, Versiti, 8733 West Watertown Plank Road, Milwaukee, WI, 53226, USA.
Kirthi PulakantiBlood Research Institute, Versiti, 8733 West Watertown Plank Road, Milwaukee, WI, 53226, USA.
Linzheng ShiBlood Research Institute, Versiti, 8733 West Watertown Plank Road, Milwaukee, WI, 53226, USA.
Alex AbelBlood Research Institute, Versiti, 8733 West Watertown Plank Road, Milwaukee, WI, 53226, USA.
Mingyu LiangDepartment of Physiology, Center of Systems Molecular Medicine, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Subramaniam MalarkannanBlood Research Institute, Versiti, 8733 West Watertown Plank Road, Milwaukee, WI, 53226, USA.
Sridhar RaoBlood Research Institute, Versiti, 8733 West Watertown Plank Road, Milwaukee, WI, 53226, USA. sridhar.rao@versiti.org.ORCID 0000-0003-2688-9541
Medical College of Wisconsin · USVersiti Blood Center of Wisconsin · USVanderbilt University · US

Funding

Cohesin Mutations in Acute Myelogenous LeukemiaR01CA204231 · NCI · VERSITI WISCONSIN, INC. · PI RAO, SRIDHAR · 2017 to 2021
$1.9M
Molecular signature of inflammationR01CA179363 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI MALARKANNAN, SUBRAMANIAM · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA179363NCI NIH HHS R01 CA204231
6 · The paper itself

Abstract

backgroundThe Tet protein family (Tet1, Tet2, and Tet3) regulate DNA methylation through conversion of 5-methylcytosine to 5-hydroxymethylcytosine which can ultimately result in DNA demethylation and play a critical role during early mammalian development and pluripotency. While multiple groups have generated knockouts combining loss of different Tet proteins in murine embryonic stem cells (ESCs), differences in genetic background and approaches has made it difficult to directly compare results and discern the direct mechanism by which Tet proteins regulate the transcriptome. To address this concern, we utilized genomic editing in an isogenic pluripotent background which permitted a quantitative, flow-cytometry based measurement of pluripotency in combination with genome-wide assessment of gene expression and DNA methylation changes. Our ultimate goal was to generate a resource of large-scale datasets to permit hypothesis-generating experiments.

resultsWe demonstrate a quantitative disparity in the differentiation ability among Tet protein deletions, with Tet2 single knockout exhibiting the most severe defect, while loss of Tet1 alone or combinations of Tet genes showed a quantitatively intermediate phenotype. Using a combination of transcriptomic and epigenomic approaches we demonstrate an increase in DNA hypermethylation and a divergence of transcriptional profiles in pluripotency among Tet deletions, with loss of Tet2 having the most profound effect in undifferentiated ESCs.

conclusionsWe conclude that loss of Tet2 has the most dramatic effect both on the phenotype of ESCs and the transcriptome compared to other genotypes. While loss of Tet proteins increased DNA hypermethylation, especially in gene promoters, these changes in DNA methylation did not correlate with gene expression changes. Thus, while loss of different Tet proteins alters DNA methylation, this change does not appear to be directly responsible for transcriptome changes. Thus, loss of Tet proteins likely regulates the transcriptome epigenetically both through altering 5mC but also through additional mechanisms. Nonetheless, the transcriptome changes in pluripotent Tet2

Indexed as

AnimalsCell DifferentiationCRISPR-Cas SystemsDioxygenasesDNA-Binding ProteinsDNA MethylationEmbryonic Stem CellsGene EditingGene Expression Regulation, DevelopmentalMiceMice, KnockoutProto-Oncogene ProteinsDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsTET1 protein, mouseTet2 protein, mouseTet3 protein, mouseDifferentiationDNA methylationEmbryonic stem cellsTen eleven translocation (TET proteins)

Identifiers

PMID31286885
PMCPMC6615237
OpenAlexW2960079805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.